Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Stem and Immune Cells in the Early Stage Breast Cancer Without Genetic Risk

NCT03870802 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT03870802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03870802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Stem and Immune Cells in the Early Stage Breast Cancer Without Genetic Risk
Lead sponsor
Centre Leon Berard
Phase
Observational
Overall status
Unknown status
Start date
February 22, 2021
Completion date
November 15, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer